Overall Weakness in the Healthcare Sector, Why These Two Stocks Are Worth Long-Term Positioning Apr 16, 2026 Life Science
Mirum Pharmaceuticals’ Stock Surged Over 120% in One Year and May Continue to Climb Apr 14, 2026 Life Science
A Melanoma Drug Successfully Launched, Yet Iovance’s Stock Has Underperformed the Market for Three Years Apr 10, 2026 Life Science
How Should Investors Position Themselves in This Year’s S&P 500 “Dark Horses” Moderna and Target? Apr 9, 2026 Consumer Goods, Life Science
Wave Life Sciences’ Weight Loss Drug Phase 1 Clinical Data Triggers Stock Volatility, Yet Differentiated Path Still Shows Promise Apr 1, 2026 Life Science
High Volatility, High Reward: Two Biotech Stocks for the Risk-Tolerant Investor Mar 26, 2026 Life Science
Who Will Be the Next Oncology Giant? Axsome and Madrigal Could Overtake by 2026 Mar 25, 2026 Life Science
Tarsus Pharmaceuticals Chief Human Resources Officer Sells Shares, Transaction Highlights Company’s Commercial Momentum Mar 25, 2026 Life Science
